BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 28, 2026
Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Cost-Cutting Measures Taken At Gene Therapy Firm Introgen

Feb. 19, 2003
By Aaron Lorenzo

$10M Private Placement Gives Onyx Added Phase III Funding

Feb. 19, 2003
By Aaron Lorenzo

Neose Secures $17M Privately To Advance Internal Programs

Feb. 18, 2003
By Aaron Lorenzo
Neose Technologies Inc. is raising $17 million through a private placement of common stock. The Horsham, Pa.-based company said late Thursday it entered into a definitive agreement to sell about 2.9 million common shares for $6 apiece. (BioWorld Today)
Read More

Neose Secures $17M Privately To Advance Internal Programs

Feb. 18, 2003
By Aaron Lorenzo
Neose Technologies Inc. is raising $17 million through a private placement of common stock. The Horsham, Pa.-based company said late Thursday it entered into a definitive agreement to sell about 2.9 million common shares for $6 apiece. (BioWorld Today)
Read More

Albany Molecular Expands Via Lilly Deal, Organichem Purchase

Feb. 14, 2003
By Aaron Lorenzo

Epimmune Plans Acquisition Of Anosys For Synergistic Platform

Feb. 14, 2003
By Aaron Lorenzo
The San Diego-based company entered a preliminary merger agreement with Anosys Inc. to create a combined entity focused on immunotherapeutics and products to treat cancer and infectious diseases. (BioWorld Today)
Read More

Epimmune Plans Acquisition Of Anosys For Synergistic Platform

Feb. 14, 2003
By Aaron Lorenzo
The San Diego-based company entered a preliminary merger agreement with Anosys Inc. to create a combined entity focused on immunotherapeutics and products to treat cancer and infectious diseases. (BioWorld Today)
Read More

Albany Molecular Expands Via Lilly Deal, Organichem Purchase

Feb. 14, 2003
By Aaron Lorenzo

Cephalon Plans $161M Purchase Of Australian Company SIRTeX

Feb. 13, 2003
By Aaron Lorenzo

Aradigm Raises $15M Through Private Placement Of Shares

Feb. 13, 2003
By Aaron Lorenzo
View All Articles by Aaron Lorenzo

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 26, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 27, 2026.
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Dice spelling out D-E-A-L-?, yes, no

    Muted and missing M&As: JPM deals absent in 2026

    BioWorld
    For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing